Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country

BACKGROUND: Although guidelines for prophylactic human papillomavirus (HPV) vaccination recommend two doses for girls ages 9–14 years, several studies have demonstrated similar protection with one dose. Our objective was to evaluate the long-term health and economic impacts of routine one-dose HPV v...

Descripción completa

Detalles Bibliográficos
Autores principales: Burger, Emily A., Campos, Nicole G., Sy, Stephen, Regan, Catherine, Kim, Jane J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066173/
https://www.ncbi.nlm.nih.gov/pubmed/29807710
http://dx.doi.org/10.1016/j.vaccine.2018.04.061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066173/
https://www.ncbi.nlm.nih.gov/pubmed/29807710
http://dx.doi.org/10.1016/j.vaccine.2018.04.061

Ejemplares similares